We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

IMRT Radiotherapy for Head and Neck Cancer May Be Superior to Standard Radiation

By HospiMedica International staff writers
Posted on 28 Jan 2014
Patients with head and neck cancer who are treated with a sophisticated form of radiation therapy may experience fewer side effects and are less likely to die from their disease than patients who receive traditional radiation therapy. More...
These new findings revealed intensity-modulated radiation therapy (IMRT) to be both a safe and valuable treatment for patients with head and neck cancer.

Patients with head and neck cancer frequently receive radiation treatments, which can cause significant side effects including dry mouth, difficulty swallowing, and bone damage. Research has shown that IMRT, an advanced radiation technique that is devised to treat tumors while sparing normal tissues, can cause less dry dental problems and dry mouth than traditional radiation; however, studies have not determined how IMRT affects patients’ survival.

To investigate, Beth Beadle, MD, PhD, from the University of Texas MD Anderson Cancer Center (Houston, USA) and her colleagues analyzed a large database of 3,172 patients treated for head and neck cancer at various clinics across the United States between 1999 and 2007. After a mid-point follow-up time of 40 months, 84.1% of patients treated with IMRT had not died from cancer, compared with 66.0% of patients treated with standard radiation. Studying each anatomic sub-site singly, all particular subgroups of patients treated with IMRT had better survival than those treated with traditional radiation.

“This analysis revealed that patients treated with IMRT have less cancer-related deaths than those treated with traditional techniques. So, not only do they have fewer side effects but they also have fewer life-threatening recurrences,” said Dr. Beadle.

The research has important bearings to discussions of healthcare delivery and healthcare policy because IMRT is more costly than standard radiation therapy. “An investment in IMRT may be cost-effective because it is better at both preventing side effects and cancer recurrence,” Dr. Beadle explained. More research is needed to verify the findings of this retrospective study, however.

The study analysis was published online January 13, 2014 in Cancer, a journal of the American Cancer Society.

Related Links:

University of Texas MD Anderson Cancer Center



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Gas Analyzer
i-Check200
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.